PCVI: VALIDATION OF EQUATIONS USED TO PREDICT WARFARIN DOSING DECISIONS  by Shermock, KM et al.
306 Abstracts
However, age along with religion and education became
the main predictors for the emotional models: social rela-
tionships and psychological aspects. Overall, age was the
most important sociodemographic variable except in the
Pain/Physical Discomfort domain where gender was most
important. In this case, men had signiﬁcantly lower scores
than women. CONCLUSIONS: Sociodemographics are
more strongly related to scores in the psychosocial
domains of health related quality of life with age being
the greatest single factor. Older individuals may be more
likely to attribute health to aspects unrelated to physi-
cal well being such as their outlook on life and social 
relationships.
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OBJECTIVES: To assess whether ﬁngerstick Interna-
tional Normalized Ratio (INR) devices lead to the same
warfarin dosing decisions as a standard method, investi-
gators commonly rely on mathematical formulas to esti-
mate clinical decision-making. Our investigation assessed
the degree to which these formulas predict actual clinical
(i.e. ‘dosing’) agreement of INR pairs. METHODS: Two
hundred two patients provided 3 INR measurements for
analysis: two from different ﬁngerstick devices and one
via reference laboratory. Actual dosing decisions (up,
down, no change) based on these INRs were made by
blinded clinicians. Actual dosing agreement based upon
the ﬁngerstick devices and the laboratory was used as a
standard to assess agreement between published, but
unvalidated, formulas. Bayesian hierarchical modeling
was used to rank the algorithms in order of their ability
to predict actual clinical decisions. An enhanced method
used bootstrapped smoothing splines to investigate agree-
ment as a function of POCT INR value. RESULTS: A
total of 14 formulas have been used to estimate warfarin
dosing decisions in 11 published investigations. The for-
mulas misclassiﬁed dosing agreement for between 19%
and 38% of paired INR values (mean: 27%). Formulas
generally misclassiﬁed fewer pairs for the device with 
less bias (range: 16%–30%) than more bias (range
23%–44%). The method that offered the best proxy (pos-
terior probability of being the best method = 70%) still
misclassiﬁed 19% of INR pairs. The smoothing spline
analysis showed that the misclassiﬁcation of pairs by
these formulas varies inconsistently throughout the INR
scale. We developed an improved formula that is likely
too complex clinical use. CONCLUSIONS: The unvali-
dated formulas routinely used to predict warfarin dosing
decision agreement misclassify a signiﬁcant proportion 
of paired INR values. More accurate formulas are too
complex to be practical. Therefore, dosing decisions
should be measured directly as opposed to predicted with
a formula.
PCV2
TELEMONITORS REDUCE HOSPITAL AND ER
ADMISSIONS FOR HOMEBOUND CONGESTIVE
HEART FAILURE (CHF) PATIENTS
Schabert VF, Johann JS, Davis N
Strategic Healthcare Programs, Santa Barbara, CA, USA
OBJECTIVES: The use of telemonitoring is receiving
increased recognition by providers and payers as a means
of decreasing healthcare costs while improving or stabi-
lizing patient outcomes. We compared hospitalizations
and ER visits for telemonitored patients before and after
they began telemonitoring. METHODS: We analyzed
415 CHF patients who were assigned HomMed SentryTM
telemonitors, an FDA-approved 510(k) device, between
October 1, 2001, and September 30, 2002. Admission
and discharge dates from telemonitoring service were
compared with standardized home health nursing 
assessments using the CMS-mandated Outcome and
Assessment Information Set (OASIS). Health status of
telemonitored patients was compared with 6509 CHF
patients from the ASK for AgenciesTM research database,
representing 218 home health agencies in 44 states. Com-
parison patients had OASIS assessments during the same
study period. Within-patient differences in the rate of hos-
pitalizations and ER visits per 100 days were reported for
telemonitored patients before and after telemonitoring.
RESULTS: Telemonitored CHF patients were more likely
to have poorly controlled CHF symptoms (45%) than
non-monitored patients (34%, p = .001), although mon-
itored and non-monitored patients were comparable on
age (78.8 vs. 79.2 years, p > .10) and estimated severity
of comorbid conditions (4.6 vs. 5.3 on a 0–16 scale, 
p > .10). Once CHF patients began telemonitoring, the
average decrease in hospitalizations was 3.2 admissions
per 100 homecare days (t = -1.98, p = .05) and decrease
in ER visits was 3.3 admissions per 100 homecare days
(t = -1.94, p = .05). CONCLUSIONS: Telemonitors are
a valuable tool for improving the functional status and
outcomes of homebound CHF patients. That telemoni-
tored CHF patients are more likely than other home-
bound CHF patients to have poorly controlled symptoms
suggests that home health agencies are assigning tele-
monitors to their most severe patients.
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